| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8217262 | International Journal of Radiation Oncology*Biology*Physics | 2015 | 9 Pages |
Abstract
In the RAPID trial, a number of patient tumor and treatment-related factors, including the use of APBI, were associated with adverse cosmesis and cosmetic deterioration. For patients treated with APBI alone, the high-dose treatment volume was not independently associated with an adverse cosmetic outcome, and a useful clinical threshold could not be identified.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
David MD, Pauline T. MD, Sameer PhD, Ivo A. MD, Tanya MD, Do-Hoon MD, Iwa MD, Isabelle MD, Alan MD, Mohamed MD, Isabelle MD, Melanie MD, Anthony MD, Theresa MD, Francisco MD, Susan MD, Sophie MD, Elizabeth MRT(T), CCRP, Timothy J. BM, BCh,